Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041

globenewswire.com
SNY MRK NVS

KOMO Biosciences Appoints Patient Advocate Tom Whitehead and Immunotherapy Pioneer Michael Kalos, Ph.D. to Advisory Board

businesswire.com
JNJ LLY NVS

PSMA-Targeted Therapy Market Set to Expand by 2034 on Strong Pipeline and Increasing Diagnosis Rates | DelveInsight

prnewswire.com
LNTH TLX NVS

Shed GLP-1 Weight Loss Review 2026: Examining the Telehealth Platform's Process, Pricing, and Medication Options

accessnewswire.com
NVS LLY

Stem Cell Banking Market Projected to Reach US$ 27.95 Billion by 2035, Supported by Advancing Clinical Development Activity | Astute Analytica

globenewswire.com
VRTX NTLA CRSP BMY NVS BGL CCEL

$612.9 Billion Pharmaceutical Packaging Market, Forecast 2033; Featuring Analysis of 20+ Industry Players | Astute Analytica

globenewswire.com
PFE NVS

$576.5 Million Fetal Alcohol Spectrum Disorder Treatment Market - Global Forecast 2026-2032

globenewswire.com
LLY JNJ PFE NVS SNY

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease

globenewswire.com
NVS

Hemophagocytic Lymphohistiocytosis Market Poised for Phenomenal Expansion in the US at a CAGR of 24.5% During the Forecast Period (2025-2034) | DelveInsight

prnewswire.com
NVS

El maratón de calidad detrás de un vaso de leche: se estrena el documental Super Milk USA - español USA - English India - English

prnewswire.com
TFPM SU NVS